EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Fucoidan Treatment Improves Diabetic Hyperglycemia and Dyslipidemia in Rodents: A Systematic Review and Meta-Analysis

Kana Watanuki, Rin Akiyama, Shiita Watanabe, Eri Adachi, Masako Shimada iD

Nutrients · 03.04.2026 · 18 (7) · 1155

DOI: 10.3390/nu18071155 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 03.04.2026. Verfasst von Kana Watanuki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nutritional Science, Sagami Women's University, 2-1-1 Bunkyo, Minami-ku, Sagamihara 252-0383, Kanagawa, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Dyslipidemias, Hyperglycemia, Polysaccharides. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sagami Women's University, Sagami Women’s University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Fucoidan is a sulfated long-chain polysaccharide found mainly in sea cucumbers and brown algae. Studies suggest that fucoidan may play a role in treating various diseases, including metabolic syndrome and diabetes mellitus. The purpose of the current study was to investigate the effects of fucoidan isolated from brown algae on diabetic hyperglycemia and dyslipidemia.

Methods

Two databases, PubMed and Embase, were searched to identify peer-reviewed articles written in English and published up to 30 June 2025. Studies reporting blood glucose and serum/plasma lipid levels of diabetic rodents treated with fucoidan or vehicle were included in the meta-analysis.

Results

Forty-seven studies reported blood glucose levels. The pooled effect size for blood glucose levels was −2.26 (95% CI: −2.78 to −1.75), with substantial heterogeneity. Subsequent analyses showed that diabetic dyslipidemia was markedly improved in the fucoidan-treated group compared with the control.

Conclusions

Fucoidan treatment could improve hyperglycemia and dyslipidemia in diabetic rodents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDyslipidemiasHyperglycemiaPolysaccharidesAnimalsRatsBlood GlucoseLipidsPhaeophyceaeRodentia

Stichwörter der Autor:innen

diabetic rodent modelsdyslipidemiafucoidanhyperglyceridemiameta-analysis

Substanzen

Blood GlucosefucoidanLipidsPolysaccharides

Autor:innen und Institutionen

  • Faculty of Nutritional Science, Sagami Women's University, 2-1-1 Bunkyo, Minami-ku, Sagamihara 252-0383, Kanagawa, Japan.
  • Graduate School of Nutritional Science, Sagami Women's University, 2-1-1 Bunkyo, Minami-ku, Sagamihara 252-0383, Kanagawa, Japan.

ORCID-Profile: Masako Shimada

Förderung

  • Sagami Women's University
  • Sagami Women’s University

Zitieren

APA

Watanuki, K., Akiyama, R., Watanabe, S., Adachi, E., & Shimada, M. (2026). Fucoidan Treatment Improves Diabetic Hyperglycemia and Dyslipidemia in Rodents: A Systematic Review and Meta-Analysis. Nutrients, 18(7), 1155. https://doi.org/10.3390/nu18071155

Vancouver

Watanuki K, Akiyama R, Watanabe S, Adachi E, Shimada M. Fucoidan Treatment Improves Diabetic Hyperglycemia and Dyslipidemia in Rodents: A Systematic Review and Meta-Analysis. Nutrients. 2026;18(7):1155. doi:10.3390/nu18071155

BibTeX
@article{Watanuki2026,
  author = {Watanuki, Kana and Akiyama, Rin and Watanabe, Shiita and Adachi, Eri and Shimada, Masako},
  title = {Fucoidan Treatment Improves Diabetic Hyperglycemia and Dyslipidemia in Rodents: A Systematic Review and Meta-Analysis},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {1155},
  doi = {10.3390/nu18071155}
}
Kostenlos starten →